Both presymptomatic individuals and RA patients who were positive for anti-CCP antibodies had higher levels of survivin (respectively P = 0.023 and P = 0.021, Mann–Whitney U test) when compared with anti-CCP negative individuals. This evidence concerns the gene BIRC5 and rheumatoid arthritis.